← All indications
Bulimia
Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
Drugs by status
Phase 4 trials (3)
Phase 3 trials (1)
Phase 2 trials (3)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (12)
- Jazz Pharmaceuticals
- Forest Laboratories
- Eli Lilly
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Mclean Hospital
- National University of Malaysia
- University of North Dakota
- Yale University
- University of Cincinnati
- Neuropsychiatric Research Institute, Fargo, ND
- Donaghue Foundation
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (17)
- Takeda
- Alkermes
- National Institute of Mental Health (NIMH)
- Multidisciplinary Association for Psychedelic Studies
- St. Luke's-Roosevelt Hospital Center
- University of Toronto
- University of Virginia
- Columbia University
- Dalhousie University
- University of Chicago
- MAPS Public Benefit Corporation
- University of North Carolina at Chapel Hill
- Charles University
- Brain & Behavior Research Foundation
- Foundation of Hope, North Carolina
- Government of Canada
- Ontario Mental Health Foundation
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (12)